ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
Dow Jones
38,675.68
1.18%
Brent Oil
82.765
0.00%
Bitcoin
63,717.99
-0.27%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Revvity Inc (RVTY) Quote

Revvity Inc

Revvity Inc (RVTY)

NYSE
100.61
-0.47
(-0.46%)
Closed May 05 4:00PM
Delayed by 15 minutes
100.61
0.00
(0.00%)
After Hours: 4:21PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
100.61
Bid
-
Ask
-
Volume
859,139
100.54 Day's Range 102.64
79.50 52 Week Range 132.00
Market Cap
12.425B
Previous Close
101.08
Open
102.49
Last Trade
115835
@
100.61
Last Trade Time
Financial Volume
$ 87,016,227
VWAP
101.2831
Average Volume (3m)
831,231
Shares Outstanding
123,529,821
Dividend Yield
0.28%
PE Ratio
17.93
Earnings Per Share (EPS)
5.61
Revenue
2.75B
Net Profit
693.09M

About Revvity Inc

PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics, and di... PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software. Show more

Sector
Lab Analytical Instruments
Industry
Engineering Services
Website
www.perkinelmer.com
Headquarters
Waltham, Massachusetts, USA
Founded
2001
Revvity Inc is listed in the Lab Analytical Instruments sector of the New York Stock Exchange with ticker RVTY. The last closing price for Revvity was $101.08. Over the last year, Revvity shares have traded in a share price range of $ 79.50 to $ 132.00.

Revvity currently has 123,529,821 shares outstanding. The market capitalization of Revvity is $12.42 billion. Revvity has a price to earnings ratio (PE ratio) of 17.93.

RVTY Latest News

More News

Revvity Announces Financial Results for the First Quarter of 2024

Revenue of $650 million; (4)% reported growth; (3)% organic growth First quarter GAAP EPS of $0.21; Adjusted EPS from continuing operations of $0.98 Reaffirms full year 2024 organic growth and...

April 29 2024
Business Wire

Revvity Board Declares Quarterly Dividend

The Board of Directors of Revvity (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 9, 2024 to all shareholders of...

April 25 2024
Business Wire

Revvity to Present at BofA Securities 2024 Health Care Conference

Revvity, Inc. (NYSE: RVTY) will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024 at 8:40 a.m. PT in Las Vegas, NV. Senior Vice President and Chief Financial...

April 25 2024
Business Wire

Revvity Unveils a New Era of Automated Tuberculosis Testing

New and improved workflow now available that pairs Revvity’s T-SPOT™.TB test with the Auto-Pure 2400 liquid handling platform Substantially lowers hands-on time, allowing for increased lab...

April 24 2024
Business Wire

Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners

New CRO system-level expansion elevates data stewardship and enables organizations to gain more insight with less oversight Today, Revvity, Inc. (NYSE: RVTY) announced that its software and...

April 15 2024
Business Wire

Revvity To Hold Earnings Call on Monday, April 29, 2024

Revvity, Inc. (NYSE: RVTY), today announced that it will release its first quarter 2024 financial results prior to market open on Monday, April 29, 2024. The Company will host a conference call...

April 04 2024
Business Wire

Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software

Today, Revvity, Inc. (NYSE: RVTY) announced that the Massachusetts Superior Court has granted a preliminary injunction compelling Cloud Software Group (CSG) to comply with its contractual...

April 02 2024
Business Wire

Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group

Asserts CSG has acted in bad faith, ignoring obligations as strategic partner for Spotfire® software Today, Revvity, Inc. (NYSE: RVTY) announced that it has filed a complaint against Cloud...

March 20 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.31-1.28532182104101.92107.34100.34831916102.65595655CS
4-1.01-0.993898838811101.62110.8297.3151012823104.42227272CS
12-2.57-2.4907927893103.18111.1897.315831231104.89847646CS
2614.6717.070048871385.9411582.17840175102.23208675CS
52-15.73-13.5207151453116.3413279.5816749106.79036581CS
156-15.73-13.5207151453116.3413279.5816749106.79036581CS
260-15.73-13.5207151453116.3413279.5816749106.79036581CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 6.8001
(254.17%)
31.01M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M
SHOTWSafety Shot Inc
$ 0.45
(45.16%)
644
AIPArteris Inc
$ 8.185
(38.03%)
1.11M
RGFReal Good Food Company Inc
$ 0.85
(37.32%)
4.26M
MNDRMobile health Network Solutions
$ 3.33
(-84.91%)
18.76M
NUVOHoldco Nuvo Group DG Ltd
$ 2.00
(-57.54%)
1.04M
SPTSprout Social Inc
$ 28.82
(-40.15%)
13.47M
UNITUniti Group Inc
$ 4.441
(-26.35%)
21.07M
IPDNProfessional Diversity Network Inc
$ 1.29
(-24.12%)
662.59k
AAPLApple Inc
$ 183.38
(5.98%)
163.22M
SQQQProShares UltraPro Short QQQ
$ 11.08
(-5.94%)
154.59M
JAGXJaguar Health Inc
$ 0.3164
(7.91%)
142.47M
NKLANikola Corporation
$ 0.6526
(6.55%)
106.88M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M

Discussion

View Full Feed
ChannelTrader ChannelTrader 2 minutes ago
Really ? it's murder just like Israel is doing...8 weeks free killing...right ?
If it was up to me, I'd put an 8 week time limit on it........4 weeks to find out you're preggers.......4 weeks to get it done.......

The key to any issue is to compromise .........and I think that'
Brucebannerr Brucebannerr 2 minutes ago
You poor stupid losers. Lmfao !
Running Wild Running Wild 3 minutes ago
"Donald Trump’s Truth Social media site has just 113,000 users and has seen a 4% drop in users over the past month and 19% this year."


Yikes!



Watch out belooooooooow!





https://www.politicususa.com/202
DJT
Zardiw Zardiw 3 minutes ago
You really haven't explained what your issues with the company are.......and a lot of the things you've posted don't make any sense.......at least not to me.............

Z
IDGR
Rising_Sun Rising_Sun 3 minutes ago
Not following you quite clearly. That meeting was dated back in 2022.

Just hoping to get approval in May so that it will bring spotlight in ASCO 2024.
NWBO
Golden Cross Golden Cross 3 minutes ago
$RDAR .001 - .00673 1-Yr Forecast by WalletInvestor - News next week and Artificial Intelligence coming to the app here. Things are looking up here!
https://twitter.com/raadr_

https://investorshub.advfn.com/uimage/uploads/2024/4/5/yallzrdar-1yr.png
RDAR
Running Wild Running Wild 4 minutes ago
BREAKING: TRUMP’S TRUTH SOCIAL FRAUD REVEALED AS NUMBERS SHOW SITE HAS ALMOST NO USERS



DJT investors are buying trump diaper farts!

It's all FAR WORSE THAN WE KNEW!!!!

"Donald Trump’s Truth Social media site has just 113,000 users and has
DJT
Tibby Tibby 4 minutes ago
Hey there I had heard from somewhere that MSX was going to be reinstated on the Board by late April 2024 . It was a slam dunk.
JTTORRES had it all under control and was going to make the authorities son and cry with guilt on their constant incredulous behavior.
Oh yes do not forget the
frrol frrol 4 minutes ago
According to Missling we are applying for full approval based on EMA feedback, but I think there's a chance that, since AD is such a pressing and large indication and our data is relatively limited, the CHMP recommends to the EMA that our application go AA and be changed to a CMA (the two are often
AVXL
satter satter 4 minutes ago
Do you identify as a stupid or an imbecile or both?
DJT
Golden Cross Golden Cross 5 minutes ago
$RDAR .001 - .00673 1-Yr Forecast by WalletInvestor - News next week and Artificial Intelligence coming to the app here. Things are looking up here!
https://twitter.com/raadr_

https://investorshub.advfn.com/uimage/uploads/2024/4/5/yallzrdar-1yr.png
RDAR
cjstocksup cjstocksup 5 minutes ago
https://x.com/simonateba/status/1787123915975770386
gail gail 5 minutes ago
the fact that they…..

…..


just became current is why i smell news and a run. but i do like the quiet “pre run” for now.
ALYI
Zardiw Zardiw 5 minutes ago
If it was up to me, I'd put an 8 week time limit on it........4 weeks to find out you're preggers.......4 weeks to get it done.......

The key to any issue is to compromise .........and I think that's a good way to settle it.

I would also make that next day 24 Hr pill re
jtsmgoblue jtsmgoblue 6 minutes ago
I expect no news until the frivolous lawsuits are closed. IMO, this window was last opportunity for the shorts to close out positions at significantly undervalued levels.

I, for one, appreciated the opportunity to buy more.

Patience
AVXL
BDEZ BDEZ 6 minutes ago
Yup..the good ole days.
cjstocksup cjstocksup 7 minutes ago
https://x.com/iluminatibot/status/1787101193132494918
Ppastis Ppastis 7 minutes ago
Wrong board my friend ??
LWLG
Whalatane Whalatane 7 minutes ago
So what would constitute a stronger dossier ...Real World Evidence studies that the previous mgt once floated ?

As you probably know ..Real World evidence studies rarely show the same degree of RR as the original trials.
This is well known and the reason is that in most CV tria
AMRN
getmoreshares getmoreshares 7 minutes ago
https://twitter.com/dfort65/status/1787173994921185777

Your Recent History

NYSE
RVTY
Revvity
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved